CIK 0001035354
- Non-accelerated filer
- Smaller reporting company
Eloxx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELOX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 841368850
- Phone
- +1 781-577-5300
- Business address
- P.O. BOX 274, ARLINGTON, MA, 02476
- Former names
- Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-03-26 | Ward Robert CHIEF EXECUTIVE OFFICER | Option exercise | +35,599 | 131,156 | ||
| 2019-03-26 | Ward Robert CHIEF EXECUTIVE OFFICER | Shares withheld for taxes | −10,467 | $11.50 | $120K | 120,689 |
| 2019-03-26 | Ward Robert CHIEF EXECUTIVE OFFICER | Option exercise · Restricted Stock Units | −35,599 | 391,591 | ||
| 2019-01-30 | Williams Gregory C. CHIEF OPERATING OFFICER | Grant or award · Stock Options | +100,000 | 100,000 | ||
| 2019-01-30 | Williams Gregory C. CHIEF OPERATING OFFICER | Grant or award · Restricted Stock Units | +30,000 | 30,000 | ||
| 2019-01-30 | Snow David P. CHIEF BUSINESS OFFICER | Grant or award · Stock Options | +55,000 | 55,000 | ||
| 2019-01-30 | Snow David P. CHIEF BUSINESS OFFICER | Grant or award · Restricted Stock Units | +25,000 | 25,000 | ||
| 2019-01-30 | Belloff Neil S. GENERAL COUNSEL/CORPORATE SECR | Grant or award · Stock Options | +50,000 | 50,000 | ||
| 2019-01-30 | Belloff Neil S. GENERAL COUNSEL/CORPORATE SECR | Grant or award · Restricted Stock Units | +25,000 | 25,000 | ||
| 2019-01-30 | WEAVER GREGORY L CHIEF FINANCIAL OFFICER | Grant or award · Stock Options | +60,000 | 60,000 | ||
| 2019-01-30 | WEAVER GREGORY L CHIEF FINANCIAL OFFICER | Grant or award · Restricted Stock Units | +20,000 | 20,000 | ||
| 2019-01-30 | Ward Robert CHIEF EXECUTIVE OFFICER | Grant or award · Stock Options | +226,000 | 226,000 | ||
| 2018-12-28 | Ward Robert CHIEF EXECUTIVE OFFICER | Gift | −50,000 | 95,557 | ||
| 2018-12-26 | Ward Robert CHIEF EXECUTIVE OFFICER | Option exercise | +213,595 | 228,595 | ||
| 2018-12-26 | Ward Robert CHIEF EXECUTIVE OFFICER | Shares withheld for taxes | −83,038 | $12.60 | $1.0M | 145,557 |
| 2018-12-26 | Ward Robert CHIEF EXECUTIVE OFFICER | Option exercise · Restricted Stock Units | −213,595 | 427,190 | ||
| 2018-06-25 | Williams Gregory C. Chief Operating Officer | Grant or award · Employee Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2018-06-25 | Snow David P. Chief Business Officer | Grant or award · Employee Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2018-06-18 | Belloff Neil S. General Counsel and Secretary | Grant or award · Employee Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2018-06-15 | Avnur Zafrira Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 |
Page 13 of 20 · 388 trades